Test Price
2,800 AED✅ Home Collection Available
ECM1 Gene Analysis for Urbach-Wiethe Disease – Next‑Generation Sequencing (Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ECM1 لمرض أورباخ-فيته بتقنية التسلسل الجيني (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Clinical & Operational Excellence
- ✓ 99.9% Diagnostic Sensitivity – ISO‑accredited NGS analysis with full gene coverage and variant interpretation aligned with ACMG 2026 guidelines.
- ✓ Premium Home Collection – Hospital‑grade phlebotomy via ISO‑certified cold‑chain logistics, available 8 AM–11 PM across the UAE.
- ✓ Post‑Test Clinical Guidance – Telephonic consultation with a DHA‑licensed genetic counsellor to interpret your NGS report.
- ✓ Insurance Support – Direct billing verification via WhatsApp at +971 54 548 8731.
التميز السريري والتشغيلي
يقدم هذا الاختبار الجيني الدقيق تحليلاً شاملاً لجين ECM1 للكشف عن مرض أورباخ-فيته باستخدام أحدث تقنيات التسلسل الجزيئي. نضمن أعلى دقة تشخيصية مع الاستشارة الوراثية الكاملة والامتثال للقوانين الإماراتية مثل المرسوم الاتحادي رقم 41 لسنة 2024 وقانون الفحوصات الجينية للقُصَّر 2026.
Comprehensive Genetic Testing for Lipoid Proteinosis
The ECM1 gene NGS test screens the entire coding region for pathogenic variants causing Urbach‑Wiethe disease (lipoid proteinosis), a rare autosomal recessive disorder. This test empowers clinicians, geneticists, and families with definitive molecular diagnosis and carrier status determination. الفحص الجيني الدقيق لتأكيد تشخيص مرض أورباخ-فيته وتحديد الحاملين للطفرة الوراثية.
| Feature | Our Genetic Test | Conventional Single‑Gene Testing |
|---|---|---|
| Methodology | Full‑gene Next‑Generation Sequencing (Illumina platform) | Sanger sequencing – limited to known hotspots |
| Variant Detection | SNVs, indels, copy number changes – all exons ±20bp splice sites | Only targeted point mutations |
| Turnaround Time | 3–4 weeks with comprehensive clinical report | 6–8 weeks, often without CNV analysis |
| Clinical Utility | Full differential – distinguishes lipoid proteinosis from mimicking disorders | May miss atypical mutations, leading to false negatives |
Clinical Interpretation & Safety Advisory
“As a clinician, I regard this NGS test as the gold standard for confirming Urbach‑Wiethe disease. However, a genetic result must always be correlated with the patient’s clinical picture – hoarseness, skin beading, and neuroimaging findings. No single laboratory value defines the prognosis; multidisciplinary follow‑up is essential.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Do not discontinue any prescribed medication or alter treatment based on this test result without consulting your physician. Genetic information informs risk; it does not replace immediate clinical management.
🚨 Patient Safety & Emergency Red Flags
- Exclusion Criteria: Individuals with unstable psychiatric conditions that may impair understanding of genetic implications, or those unable to provide informed consent (mandatory genetic counselling per UAE CDS Law 2026 for minors).
- Post‑Collection Emergency: If you experience severe dizziness, fainting, or signs of infection at the draw site, seek immediate medical attention.
- Result Interpretation: A positive result is not a diagnosis in isolation – follow‑up with a clinical geneticist is mandatory.
- Data Privacy: All genetic data is processed in compliance with UAE PDPL and stored in DHA‑licensed encrypted servers.
Frequently Asked Questions – ECM1 Gene NGS Test
1. How reliable is the Genetic Test for detecting Urbach‑Wiethe disease?
Our full‑gene sequencing achieves over 99.9% analytical sensitivity and specificity, detecting nearly all pathogenic single‑nucleotide variants and exon‑level deletions. This makes it the most comprehensive molecular diagnostic tool for lipoid proteinosis, validated according to ISO 9001:2015 and DHA proficiency testing standards.
2. هل يُغطي الاختبار جميع الطفرات الجينية المرتبطة بمرض أورباخ-فيته؟ (Does the test cover all genetic variants linked to Urbach‑Wiethe disease?)
يغطي التحليل جميع الإكسونات والمواقع الحدودية للجين ECM1، مما يكشف أكثر من 98% من الطفرات المسببة للمرض المعروفة. We sequence the entire coding region and adjacent splice sites; rare deep‑intronic or regulatory variants may require additional investigation, but the current coverage is the highest clinically available.
3. What is the sample required, and can it be collected at home?
A simple blood draw, extracted DNA, or a single drop of blood on an FTA card is sufficient – we offer VIP home collection across the UAE. Our phlebotomists bring cold‑chain transport and can perform the draw within 60 minutes of booking. You must provide a clinical history and attend a pre‑ genetic counselling session (tele‑session available) to map your family pedigree.
UAE Regulatory Compliance: Federal Decree‑Law No. 41 of 2024 (Art. 87) | CDS Law 2026 (Genetic Testing of Minors) | UAE PDPL (Data Privacy).
Facility License: 9834453 | ISO 9001:2015 Cert: INT/EGQ/2509DA/3139.
Contact: +971545488731 | WhatsApp support for insurance verification.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians